Report 68: 34 Blood Vessel Inflammation, Vasculitis, Adverse Events Occurred In First 90 Days After Pfizer MRNA "Vaccine" Rollout, Including One Fatality. Half Had Onset Within Three Days Of Injection. 81% Of Sufferers Were Women.

 The search criterion for this System Organ Class was "Vasculitides." Vasculitis, a.k.a., vasculitides, is inflammation of a blood vessel or multiple blood vessels.

The inflammation can be related to a direct immune attack on the cells of the blood vessel or to deposits of complexes of antibody and an antigen that is not part of the blood vessel itself.

It is important to note that the adverse events in the 5.3.6 document were reported to Pfizer for only a 90-day period starting on December 1, 2020, the date of the United Kingdom's public rollout of Pfizer's COVID-19 experimental mRNA "Vaccine" product.

34 vasculitis adverse events were reported among 32 cases.

Onset time from injection to symptom onset was <24 hours to 19 days, with half occurring within three days of receiving the vaccine.

32% of vasculitis adverse events were related to skin rashes, including cutaneous vasculitis, vasculitic rash, hypersensitivity vasculitis, and palpable purpura.

Three cases of peripheral ischemia, inflammation of blood vessels to the point of impairing blood flow, were reported.

https://dailyclout.io/report-68-34-blood-vessel-inflammation-vasculitis-adverse-events/